Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of bio-pharmaceutical products. The company develops recombinant proteins, subunit and live attenuated vaccines, monoclonal antibodies and viral vectors.
This information is reserved for PitchBook Platform users. To explore Novasep Belgium‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.